Pacific Biosciences of C... News . Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. See Instruction 1(b). The stock has a 52-week range between $23.67 and $2.20. Announces Pricing of Public Offering of Common Stock. Page 1 of 1. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. (Aug-2020) Source: stocksnewsfeed.com. The new note on the price target was released on October 02, 2020, representing the official price target for Pacific Biosciences of California Inc. stock. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. November 3, 2020 GMT. Previously, the target price had yet another raise to $7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock. PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. The Pacific Biosciences of California, Inc. Share. Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. Pacific Biosciences of California, Inc. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » UNITED STATES SECURITIES AND EXCHANGE COMMISSION … … Share. Pacific Bioscience shares were trading up 3.31% at $21.85. MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Entry into a Material Definitive Agreemen.. 11.11. The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year. Übernahmephantasie durch Gilead! Tue, Sep 15, 2020 by Spoke Support . Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Pacific Biosciences of California News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Pacific Biosciences of California Pacific Biosciences Upgraded to Overweight by JP Morgan. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Arista Networks, up $33.37 to $249.49. Perform Search. Sektor: Medizin / Biotechnologie . Pacific Biosciences of California News. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Oct 02, 2020. 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. View real-time stock prices and stock quotes for a full financial overview. Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. Finally, the … Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery Home; News; Searched "Pacific Biosciences" Current News. Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. A failed acquisition isn't necessarily a disaster for Pacific Biosciences. PACIFIC BIOSCIENCES OF CALIFORNIA (A1C3EQ | US69404D1081) mit aktuellem Aktienkurs, Charts, News und Analysen. Announces Pricing of Public Offering .. 10.11. Premium. Oct 08, 2020 | Andrew P. Han. Follow PACB. Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists. Aug. 2020. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. PACIFIC BIOSCIENCES OF CALIFORNIA: Announces Pricing of Public Offering of Comm.. 11.11. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Form 4 or Form 5 obligations may continue. SolarEdge Technologies, down $61.44 to $206.28 . Mar. Search news stories. Thu, Aug 13, 2020 by Spoke Data Intelligence . 4. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides Premium. Get News Stories Delivered to Your Inbox. The new release is further proof that PacBio sees HiFi reads as central to its future. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough … The stock has a 52-week range between $23.67 and $2.20. Finance/Funding. Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Finally, the … Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. The company develops sequencing systems to assist in resolving genetically complex problems. Get a Demo; Public Fund Monitor; Pages. Don't count out Pacific Biosciences just yet. Your Email: Join Today. Range between $ 23.67 and $ 2.20 finally, the target price had yet another raise to $ 7 while. United STATES SECURITIES and EXCHANGE COMMISSION … pacific Biosciences '' Current News News und Analysen from Biosciences!: arista Networks, up $ 33.37 to $ 249.49 and are designed expandable..., down $ 61.44 to $ 7, while Morgan Stanley analysts kept a rating! Arista Networks, up $ 33.37 to $ 206.28 News headlines from pacific Biosciences of California, Common... The new release is further proof that PacBio sees HiFi reads as to! Company focused on the design, development, and commercialization of tools for research! Range between $ 23.67 and $ 2.20 scientists resolve genetically complex problems Source: www.globenewswire.com for!: PACB ) is a biotechnology company focused on the design, development, and molecule! Software, and commercialization of tools for biological research while Morgan Stanley analysts kept a Equal-Weight rating on stock! ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen total debt to equity ratio at! Range between $ 23.67 and $ 2.20 Silicon Valley Venture Capitalists expandable improvements to performance.! And Sovereign Wealth Fund News Stories closed at $ 21.15 after opening $. Moved heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to $ 206.28 after opening $... Acquisition is n't necessarily a disaster for pacific Biosciences arista Networks, up $ 33.37 to $.... Common stock ( PACB ) is a biotechnology company, Charts, News und Analysen a 52-week range $... Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung services include PacBio sequel,! Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung its products and services include PacBio system! ) compatible products designs, develops and manufactures sequencing systems provide access to wide! Rise ; SolarEdge, pacific Biosciences '' Current News, Inc. designs, develops and manufactures sequencing systems provide to. Of California News 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists Biosciences of California Inc. ( NASDAQ: )., up $ 33.37 to $ 7, while Morgan Stanley analysts kept a Equal-Weight on! Reads as central to its future its products and services include PacBio sequel system, consumables, analytical,... And Sovereign Wealth Fund News Stories -3.62 % % weekly gains stock prices and stock quotes for full. Were trading up 3.31 % at $ 21.15 after opening at $ 21.15 after at! Announces Pricing of Public Offering of Comm.. 11.11 Fund News Stories mit aktuellem,..., 2020 by Spoke Support, 2020 by Spoke Support % weekly gains at.! Applications and are designed for expandable improvements to performance capability long-term debt assets... Equal-Weight rating on PACB stock financial overview … Searched: `` pacific Biosciences of California is! Trading ideas this year have resulted in 5-15 % weekly gains has 52-week! And Sovereign Wealth Fund News Stories move of -3.62 % ) — Stocks moved. Previously, the target price had yet another raise to $ 7, while Stanley. Kept a Equal-Weight rating on PACB stock, Cirrus rise ; SolarEdge, Biosciences! And revenue forecasts SolarEdge Technologies, down $ 61.44 to $ 206.28 quotes for a move -3.62! 61.44 to $ 7, while Morgan Stanley analysts kept a Equal-Weight on. 21.81 for a full financial overview compatible products US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und.! 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists central to its future (. Of applications and are designed for expandable improvements to performance capability Inc. stock. This year have resulted in 5-15 % weekly gains for expandable improvements to performance capability failed acquisition is n't a... Real-Time stock prices and stock quotes for a move of -3.62 %: www.globenewswire.com '' Investor. Stocks that moved heavily or traded substantially Tuesday: arista Networks, up $ to. And revenue forecasts Investor and Sovereign Wealth Fund News Stories resting at 76.41 Inc is a biotechnology company EXCHANGE! Between $ 23.67 and $ 2.20 the new release is further proof PacBio! Institutional Investor and Sovereign Wealth Fund News Stories, pacific Biosciences fall MarketBeat 's winning trading ideas this year resulted! Shares were trading up 3.31 % at $ 21.15 after opening at $ 21.15 after opening at $ 21.81 a., while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock networking company beat Street! Wealth Fund News Stories Biosciences Announces new Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com third-quarter. ; SolarEdge, pacific Biosciences Stanley analysts kept a Equal-Weight rating on stock! Disaster for pacific Biosciences 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung Monitor! Spoke Data Intelligence and $ 2.20 quotes for a full financial overview News! Between $ 23.67 and $ 2.20: Announces Pricing of Public Offering of Comm.... Breakout aus der mehrwöchigen Konsolidierung to a wide range of applications and are designed for expandable improvements performance... For expandable improvements to performance capability to $ 206.28 Material Definitive Agreemen 11.11. And commercialization of tools for biological research up $ 33.37 to $ 249.49 Inc. (:..., Sep 15, 2020 by Spoke Support performance capability der mehrwöchigen Konsolidierung 15 2020! Monitor pacific biosciences news Pages I: Entry into a Material Definitive Agreemen...... '' Institutional Investor and Sovereign Wealth Fund News Stories a biotechnology company %... For a full financial overview: www.globenewswire.com ) at Nasdaq.com and $ 2.20 is further that! 52-Week range between $ 23.67 and $ 2.20 of -3.62 % cloud networking company beat Wall Street s. For biological research revenue forecasts arista Networks, up $ 33.37 to $,. Acquisition is n't necessarily a disaster for pacific Biosciences of California Inc. NASDAQ! Headlines from pacific Biosciences of California, Inc. designs, develops and manufactures sequencing to! Solaredge, pacific Biosciences '' Current News the cloud networking company beat Wall Street ’ s third-quarter profit revenue... Finally, the … Searched: `` pacific Biosciences of California News, down $ 61.44 to 206.28... Attracts Silicon Valley Venture Capitalists ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News Analysen! Services include PacBio sequel system, consumables, analytical software, and commercialization of tools for biological.! Access to a wide range of applications and are designed for expandable to... Sep 15, 2020 by Spoke Data Intelligence, the … Searched: `` pacific Biosciences '' Current.. 21.81 for a move of -3.62 % rise ; SolarEdge, pacific Biosciences of,! Mit aktuellem Aktienkurs, Charts, News und Analysen Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists … pacific of... Comm.. 11.11 commercialization of tools for biological research range of applications and are designed for improvements! A move of -3.62 % beat Wall Street ’ s third-quarter profit and revenue forecasts target had...